JP2005519905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519905A5 JP2005519905A5 JP2003561574A JP2003561574A JP2005519905A5 JP 2005519905 A5 JP2005519905 A5 JP 2005519905A5 JP 2003561574 A JP2003561574 A JP 2003561574A JP 2003561574 A JP2003561574 A JP 2003561574A JP 2005519905 A5 JP2005519905 A5 JP 2005519905A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- pharmaceutical formulation
- tucaresol
- mpl
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201736.6A GB0201736D0 (en) | 2002-01-25 | 2002-01-25 | DNA dosage forms |
| GB0201735A GB0201735D0 (en) | 2002-01-25 | 2002-01-25 | DNA dosage forms |
| PCT/GB2003/000336 WO2003061629A2 (en) | 2002-01-25 | 2003-01-23 | Dna dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519905A JP2005519905A (ja) | 2005-07-07 |
| JP2005519905A5 true JP2005519905A5 (https=) | 2006-02-09 |
Family
ID=27614803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003561574A Pending JP2005519905A (ja) | 2002-01-25 | 2003-01-23 | Ｄｎａの製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050085434A1 (https=) |
| EP (1) | EP1467711B1 (https=) |
| JP (1) | JP2005519905A (https=) |
| AT (1) | ATE357219T1 (https=) |
| CA (1) | CA2473717A1 (https=) |
| DE (1) | DE60312645T2 (https=) |
| ES (1) | ES2285087T3 (https=) |
| WO (1) | WO2003061629A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100471486C (zh) * | 2002-08-12 | 2009-03-25 | 戴纳伐克斯技术股份有限公司 | 免疫调节组合物,其制备方法和使用方法 |
| AU2002951692A0 (en) * | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| GB0423681D0 (en) * | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
| WO2007015510A1 (ja) * | 2005-08-02 | 2007-02-08 | Santen Pharmaceutical Co., Ltd. | 熱的に不安定な薬物の分解抑制方法 |
| JP5252787B2 (ja) * | 2005-08-02 | 2013-07-31 | 参天製薬株式会社 | 熱的に不安定な薬物の分解抑制方法 |
| US8512679B2 (en) | 2011-03-04 | 2013-08-20 | Elwha Llc | Glassy compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69034053T2 (de) * | 1989-06-26 | 2003-12-04 | Powderject Vaccines, Inc. | Transformation von tierischen somatischen zellen mittels partikeln |
| DK28792D0 (da) * | 1992-03-04 | 1992-03-04 | Novo Nordisk As | Nyt enzym |
| CA2160878A1 (en) * | 1993-04-19 | 1994-10-27 | Medisorb Technologies International L.P. | Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| DK0690732T3 (da) * | 1994-01-21 | 2003-05-19 | Powderject Vaccines Inc | Gasdrevet genindførselsinstrument |
| ATE252373T1 (de) * | 1994-08-04 | 2003-11-15 | Elan Drug Delivery Ltd | Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| JP4386965B2 (ja) * | 1996-04-26 | 2009-12-16 | メルク エンド カンパニー インコーポレーテッド | Ｄｎａワクチン製剤 |
-
2003
- 2003-01-23 AT AT03700947T patent/ATE357219T1/de not_active IP Right Cessation
- 2003-01-23 WO PCT/GB2003/000336 patent/WO2003061629A2/en not_active Ceased
- 2003-01-23 CA CA002473717A patent/CA2473717A1/en not_active Abandoned
- 2003-01-23 US US10/502,290 patent/US20050085434A1/en not_active Abandoned
- 2003-01-23 DE DE60312645T patent/DE60312645T2/de not_active Expired - Fee Related
- 2003-01-23 EP EP03700947A patent/EP1467711B1/en not_active Expired - Lifetime
- 2003-01-23 ES ES03700947T patent/ES2285087T3/es not_active Expired - Lifetime
- 2003-01-23 JP JP2003561574A patent/JP2005519905A/ja active Pending
-
2007
- 2007-06-01 US US11/756,817 patent/US20080095854A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004523498A5 (https=) | ||
| JP2004529078A5 (https=) | ||
| JP2004532810A5 (https=) | ||
| JP2003520232A5 (https=) | ||
| JP2001194792A5 (https=) | ||
| JP2002506648A5 (https=) | ||
| JP2006517944A5 (https=) | ||
| RU2489151C3 (ru) | Фармацевтическая комбинация, содержащая ингибитор sglt2 | |
| DE602004010493D1 (de) | Kaugummi in der form von mehrschichttabletten | |
| DE60038304D1 (de) | Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen | |
| JP2005526016A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2005538045A5 (https=) | ||
| DK1345595T3 (da) | Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse | |
| JP2005519905A5 (https=) | ||
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| JP2002022755A5 (https=) | ||
| JP2006505391A5 (https=) | ||
| JP2000141643A5 (https=) | ||
| JP2004517961A5 (https=) | ||
| AU2002330233A1 (en) | Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same | |
| JP2005536763A5 (https=) | ||
| JP2004526429A5 (https=) | ||
| JP2007513894A5 (ja) | Ｃｈｐ−ゲムシタビン複合剤および抗腫瘍剤、特に抗転移剤としてのその使用 |